Summary
holding ALJ's decision not substantially justified where the ALJ failed to discuss significant, probative record evidence contrary to the ALJ's findings
Summary of this case from Rosemary V. v. SaulOpinion
No. 14-35204
04-15-2016
NOT FOR PUBLICATION
D.C. No. 3:11-cv-05763-BHS MEMORANDUM Appeal from the United States District Court for the Western District of Washington
Benjamin H. Settle, District Judge, Presiding Before: PREGERSON, LEAVY and OWENS, Circuit Judges.
This disposition is not appropriate for publication and is not precedent except as provided by 9th Cir. R. 36-3.
After an Administrative Law Judge ("ALJ") issued a partially favorable decision, Michael McLean filed a complaint for judicial review in federal district court. The district court entered judgment in favor of McLean, reversing and remanding for further proceedings. The district court, however, denied McLean's motion for attorneys fees under the Equal Access to Justice Act ("EAJA"). McLean appeals only the district court's order denying his motion for attorneys fees under EAJA.
We have jurisdiction under 28 U.S.C. § 1291. We review the district court's decision denying attorneys fees for abuse of discretion. Tobeler v. Colvin, 749 F.3d 830, 832 (9th Cir. 2014). We reverse and remand for an award of fees because the ALJ's decision that McLean experienced medical improvement on October 25, 2007, was not substantially justified.
First, the ALJ failed to discuss significant, probative record evidence that was clearly contrary to her finding that McLean stopped taking his medication due to an improvement in his symptoms. The ALJ's mischaracterization of, and failure to weigh properly, the record evidence cannot be said to be justified to a degree that could satisfy a reasonable person. Meier v. Colvin, 727 F.3d 867, 870, 872 (9th Cir. 2013); cf. Sampson v. Chater, 103 F.3d 918, 921-22 (9th Cir. 1996). Second, the ALJ violated the agency's own regulations in failing to discuss the side effects of McLean's medication and failing to address explicitly whether the side effects supported adequately the decision to temporarily discontinue use of his mental health medication. Gutierrez v. Barnhart, 274 F.3d 1255, 1259 (9th Cir. 2001); SSR 96-7p, 1996 WL 374186 (July 2, 1996); 20 C.F.R. §§ 404.1529(c)(3)(iv), 416.929(c)(3)(iv). The ALJ's failure to credit McLean's symptom testimony was not harmless because it affected the ultimate determination that he experienced medical improvement as of October 25, 2007. Molina v. Astrue, 674 F.3d 1104, 1115 (9th Cir. 2012).
Where, as here, the ALJ's decision was not substantially justified, this court need not reach the issue of whether the Commissioner's litigation position was substantially justified. Tobeler, 749 F.3d at 832. We therefore reverse the district court's order and remand for an award of EAJA fees.
REVERSED and REMANDED.